Letko, Brosseau & Associates’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-700
| Closed | -$12.1K | – | 105 |
|
|
2024
Q1 | $12.1K | Hold |
700
| – | – | ﹤0.01% | 102 |
|
|
2023
Q4 | $8.97K | Hold |
700
| – | – | ﹤0.01% | 96 |
|
|
2023
Q3 | $25.9K | Hold |
700
| – | – | ﹤0.01% | 98 |
|
|
2023
Q2 | $28.2K | Hold |
700
| – | – | ﹤0.01% | 94 |
|
|
2023
Q1 | $50.8K | Hold |
700
| – | – | ﹤0.01% | 89 |
|
|
2022
Q4 | $57.4K | Buy |
700
+72
| +11% | +$5.9K | ﹤0.01% | 97 |
|
|
2022
Q3 | $59K | Hold |
628
| – | – | ﹤0.01% | 99 |
|
|
2022
Q2 | $122K | Hold |
628
| – | – | ﹤0.01% | 95 |
|
|
2022
Q1 | $146K | Hold |
628
| – | – | ﹤0.01% | 98 |
|
|
2021
Q4 | $247K | Buy |
+628
| New | +$247K | ﹤0.01% | 101 |
|